United Therapeutics Corp (NASDAQ: UTHR): Analysts expect the company to be under significant ... analysts believe that the stock will cool in 2015. The stock’s high valuation relative to peers, along with rate pressure and the company’s …
Biotechnology company United Therapeutics Corporation (UTHR), Tuesday, reported a narrower loss for the ... Per-share data have been adjusted to reflect a two-for-one stock split effected on September 22, 2009. Total revenue grew to …
United Thera (Nasdaq: UTHR) 18.39% HIGHER; beat Q2 EPS by 16 cents. VI Tech (Nasdaq: VITX) 18.15% HIGHER; SG Cowen stated coverage the stock; tellings clinets to buy. Herbalife (NYSE: HLF) 15.04% HIGHER; guided FY higher. …
Given up for dead just weeks ago the biotech sector is suddenly back with a vengeance. Seemingly everyone’s favorite …
Description: United Therapeutics develops and makes medicines for cardiovascular conditions, cancer and infectious diseases. Developments: Executives at United Therapeutics are hoping this year will be as good as 2004. Last year the …